Yes. Since February 2025, esketamine nasal spray (Spravato) is reimbursed by Czech health insurers for adults under 65 with treatment-resistant depression — a moderate-to-severe episode, without psychotic symptoms, that has not responded to at least two antidepressants at adequate dose and duration. For patients who meet those criteria, treatment is covered by public insurance, and a documented exceptional route exists for cases outside them. This page covers exactly who qualifies, how the pathway runs, what you pay, and what to do if you fall outside the criteria; the eligibility decision itself always sits with a clinician, and you can begin orienting yourself with our eligibility check.
What is covered
Czech public insurers have covered esketamine nasal spray since February 2025, with the reimbursement conditions running through the state drug agency SÚKL. Coverage follows the treatment as it is actually delivered: supervised administration and the post-dose observation period at equipped psychiatric facilities — Prague's Bohnice hospital, for example, operates a dedicated esketamine centre — alongside a continuing oral antidepressant.
Czechia also has a coverage feature no other European country has: partial insurer coverage of ketamine-assisted psychotherapy. Prague's Psyon clinic holds contracts with seven Czech insurers — VZP, VoZP, ČPZP, ZP MV ČR, OZP, RBP and ZP Škoda. For their clients, most outpatient psychiatric care and psychotherapy is covered, and the ketamine-assisted component is covered partially. Elsewhere in Europe, KAP is purely self-pay.
Who qualifies
The standard reimbursement criteria are:
- An adult under 65;
- A moderate-to-severe depressive episode without psychotic symptoms — non-psychotic treatment-resistant depression;
- No response to at least two antidepressants taken at adequate dose and duration in the current episode.
The practical currency is a written treatment history: every antidepressant tried in the current episode, with substance, dose, duration and outcome. Assembling proof of two adequate failed treatments is often the slower part of the whole process, so put the record together before the first appointment — it does more work than anything you say in the room.
Who decides and how to apply
The route runs through a psychiatrist — your GP can refer you, or you can approach psychiatric care directly. Within the standard criteria, insurers cover treatment per the SÚKL reimbursement conditions, applied by the treating facility. Beyond the standard criteria, Czechia works as a pre-approval system: the treating center submits a written request to your insurer, whose physician reads your documented history before the first dose is scheduled — a step that can add several weeks, so ask the center to start it early.
Administration and observation happen at equipped psychiatric facilities, and finding one with capacity is a real part of the task. To see who is listed near you, browse providers in Czechia; for the full picture of every legal route in the country, see our Czechia access guide.
What it costs you
For patients who meet the criteria, Spravato treatment is covered by public insurance; waiting depends mostly on appointment availability at an equipped centre and on how quickly your documentation comes together. At Psyon, the ketamine-assisted component is covered partially, with a meaningful self-pay share remaining; a clinic subsidy program exists for those who cannot afford standard prices. Ask for a written cost breakdown for your insurer before starting.
If you do not qualify
- Exceptional individual reimbursement. Czech insurers have a documented practice of covering Spravato beyond the standard criteria — for example for patients over 65 — when all other options are exhausted. It is case-by-case and needs a specialist willing to argue your case, but an age cut-off is not always the end of the road.
- Ketamine-assisted psychotherapy at Psyon applies broader indications after its own screening: depressive syndrome, anxiety disorders, PTSD and eating disorders, for adults 18 or older with at least one prior treatment attempt. For what to check at any private clinic, see our clinic-choice guide.
- Clinical trials are free by definition, and Czechia's research scene — anchored by NUDZ — is unusually strong; see the trials guide for how to search.
Czechia's medical psilocybin framework became law on 1 January 2026, but treatment has not started and no funding route is defined yet — it is not an option you can book today.
Frequently asked questions
Is Spravato reimbursed in Czechia?
Yes. Since February 2025, Czech health insurers cover esketamine nasal spray for adults under 65 with non-psychotic treatment-resistant depression after at least two adequate failed antidepressants, under conditions set through SÚKL. For patients who meet the criteria, treatment is covered.
I am over 65 — is that final?
Not always. Insurers can grant exceptional individual reimbursement beyond the standard criteria when all other options are exhausted, and patients over 65 are the documented example. It is decided case-by-case, and it runs on your specialist's written argument and your treatment record.
Does Czech insurance pay for ketamine-assisted psychotherapy?
Partially, and only through Psyon's contracts with seven insurers: most outpatient psychiatry and psychotherapy is covered, the ketamine-assisted component partially, with a meaningful self-pay share. Get a written breakdown for your insurer before starting.
How does Czechia compare with the rest of Europe?
Its two-antidepressant threshold matches most reimbursing countries, while the documented exceptional-approval route and the partial KAP coverage are unusual advantages. See the Europe-wide reimbursement map for the full comparison.
Sources
- SÚKL — State Institute for Drug Control
- Blossom: Medical access in Czechia
- Psyon — psychedelic clinic, Prague: services, insurers and admission criteria
- EMA: Spravato (esketamine) EPAR
- Reimbursement Pathways for Psychedelic Therapies in Europe — Magnetar Access × Blossom (2025)
This guide is for general information only and is not medical advice, a diagnosis, or a recommendation of any treatment. Regulations and reimbursement rules change; always verify current requirements with your insurer and discuss your options with a licensed clinician who knows your history. If you are in crisis, contact your local emergency number or a crisis line immediately.
This guide awaits review by a licensed medical professional.